.
-Breastfeeding
-Treatment limited to 7 days to avoid bacterial resistence
-Prior to supply, impetigo must be diagnosed, and other conditions that mimic impetigo excluded.
-exclude underlying causes of impetigo if applicable.
-Fusidic acid can cause irritation of the conjunctiva, so care must be taken to avoid the eyes when applying cream to the face
-Where there is doubt, treatment should not be initiated until the patient has sought advice from the appropriate healthcare professional
Prior to supply and where indicated, medication that the patient is using should be checked for product interactions using the British National Formulary (BNF) and SPC. This includes checking that the patient’s medication does not suggest conditions that are excluded from treatment under this PGD.
• No interaction studies have been performed. Interactions with systemically administered medicinal products are considered minimal as the systemic absorption of fusidic acid is negligible
Discuss with patient and document the reasons for exclusion from treatment under the PGD. • If the patient has consented, refer them to their GP and/or inform their GP. • Signpost to other services if appropriate. • Document the reasons for exclusion and any action taken, in the patient’s medication record. • When treatment is postponed reschedule as appropriate. • Advise patients that impetigo is extremely contagious, and measures must be taken to prevent spreading the infection (2).
Ensure patient/carer fully understands the risks of declining the service. • Advise the patient/carer about the benefits of the service. • Refer patient to GP if appropriate. • Document the reasons for declining the service and any action taken, including advice given to the patient. • Reschedule treatment if appropriate. • Explain NHS eligibility for this service where appropriate. • Advise patients that impetigo is extremely contagious, and measures must be taken to prevent spreading the infection
Click to view pharmadoctor terms & conditions.
